- Joined
- 22 June 2009
- Posts
- 21
- Reactions
- 0
Any thoughts on this stock. I have been following this company for sometime now and see that they have just taken over another Pearl Company.
rod
rod
I ran my ruler over ATP again after our chat the other day. As you say they have made great progress, moving to real profitability with decent FCF. I was also impressed with management’s capital allocation in using the cash generated to pay down the remaining debt. The business certainly looks really cheap on current financials. My first concern is just how sustainable those financials are and in reading the Annual Report in detail, particularly in the Explanatory Notes section, I was left feeling there was just too much uncertainty about this in the future.
Specifically its the risks associated with large biological assets on the balance sheet and the probabilistic gymnastics required to try and understand the range of outcomes. So we have disease risks, climate/weather risks, pricing risks, market risks, FX risks, discount rate risks, cost risks, just to name some that spring to mind. As the notes show, these variables can all have significant impact on the financials, specifically FCF. Each of them have the potential to impact outcomes that range from strongly negative to strongly positive. A lot of this is fundamental to agri/aquaculture as an industry, basically commodity traders with extra risks from biological assets,
For me a decision to invest is always built up from a consideration of how likely it is that I will lose capital and in a case like ATP I simply cant get a quantitive feeling for that risk and therefore although I think the price and current financials suggest a good opportunity for long term returns for a shareholder, it remains un-investible for me.
In the past I probably would have taken a small, speculative position just in case the bull thesis continued to play out, but as you correctly pointed out when we last spoke, a speculative position is simply gambling and I dont want to gamble. I have played that game in the past and I can’t think of a single time where it actually worked out for me. The only saving grace was I at least sized for risk and didn’t lose too much capital each time!
If I strip out biological assets ($17.5m) the company has around $7m in net assets to $11.5m in market cap - which is not unreasonable in my opinion. Taking out revaluing of biological assets from the P&L statement and very roughly I get the red line below (I couldn't be bothered to correct for things like one-offs, etc.) Even 2.5m or so profit for last year is not too bad either. I'm seeing that they spend around $17.5m/year and so long as revenue is above that they should be ok.I did a fairly deep dive into it after a fellow investor spoke to me about it. Decided it wasn't for me. This is from the email I sent him,
Pardon the pun but one doesn't have to deep dive any more, for pearls.I did a fairly deep dive into it
If I strip out biological assets ($17.5m) the company has around $7m in net assets to $11.5m in market cap -.....
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.